Skip to main content
Top

Pediatric Drugs

Issue 6/2023

Content (10 Articles)

Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward

Narendra Kumar Bagri, Christine Chew, A. V. Ramanan

Acne Inversa Review Article

Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options

Nicholas Chiang, Cathryn Sibbald, Rebecca Levy, Irene Lara-Corrales

Open Access Bronchial Asthma Review Article

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab

Yoni E. van Dijk, Niels W. Rutjes, Korneliusz Golebski, Havva Şahin, Simone Hashimoto, Anke-Hilse Maitland-van der Zee, Susanne J. H. Vijverberg

Opioids Original Research Article

Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit

Reuth Nir, Francesca Sperotto, Manasee Godsay, Minmin Lu, John N. Kheir

Myelodysplastic Syndrome Original Research Article

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)

Alba Rubio-San-Simón, Natasha K. A. van Eijkelenburg, Raoull Hoogendijk, Henrik Hasle, Charlotte M. Niemeyer, Michael N. Dworzak, Marco Zecca, Marta Lopez-Yurda, Julie M. Janssen, Alwin D. R. Huitema, Marry M. van den Heuvel-Eibrink, Eric J. Laille, Harm van Tinteren, Christian M. Zwaan

Open Access Correction

Correction to: Viloxazine: Pediatric First Approval

Yvette N. Lamb